Therapeutic effectiveness of virtual reality-based exercise through Oculus Quest 2 on balance, dizziness, nystagmus and quality of life in patients with posterior canal benign paroxysmal positional vertigo -A randomized control trial.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 74
- 试验地点
- 1
- 主要终点
- 3.Quality of Life Scale (QOLS)
研究概览
简要总结
One of the most frequent causes of vertigo, theabrupt sensation that you are spinning or that the interior of your head iswhirling, is benign paroxysmal positional vertigo (BPPV). Mild to severevertigo might appear briefly as a result of BPPV. Virtual reality (VR), in which participants interface with a computer bymoving their bodies, is a novel method of therapy in rehabilitation settings.It produces a virtual environment in three dimensions using a computersimulation that affects the user’s senses of sight and sound, creating thefeeling of being lost in it. The aim of the study isto evaluate the therapeutic effect of oculus quest 2 guided physical therapy inadjunct to conventional therapy on balance, dizziness, nystagmus and quality oflife in patients with Posterior canal Benign Paroxysmal Positional Vertigo(PC-BPPV). In this study, 74 subjects will be recruited according to inclusion and exclusion criteria. Participants will be divided into group A (conventional) and group B (interventional). The data will be collected and statistically evaluated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Both Males and Females between 20 to 50 years, diagnosed will positive Loaded Dix-Hallpike test for PC-BPPV.
- •2.Patients with Dizziness Handicap Inventory score < 52 3.Patients who are willing to participate in the study.
排除标准
- •Patients with Central vestibular dysfunction, Cerebellar dysfunction, Cognitive impairments, and migraines.
- •2.Patients with Dizziness Handicap Inventory score ≥ 52 3.Patients with inner ear infections and auditory dysfunctions.
- •4.Patients under medications.
- •5.Enrolment in another clinical trial involving physiotherapy or an investigational drug.
结局指标
主要结局
3.Quality of Life Scale (QOLS)
时间窗: 1.Berg Balance Scale (BBS) at baseline and 4 weeks. | 2.Dizziness Handicap Inventory (DHI) at baseline and 4 weeks. | 3.Quality of Life Scale (QOLS) at baseline and 4 weeks. | 4.Nystagmus time at baseline and 4 weeks.
1.Berg Balance Scale (BBS)
时间窗: 1.Berg Balance Scale (BBS) at baseline and 4 weeks. | 2.Dizziness Handicap Inventory (DHI) at baseline and 4 weeks. | 3.Quality of Life Scale (QOLS) at baseline and 4 weeks. | 4.Nystagmus time at baseline and 4 weeks.
2.Dizziness Handicap Inventory (DHI)
时间窗: 1.Berg Balance Scale (BBS) at baseline and 4 weeks. | 2.Dizziness Handicap Inventory (DHI) at baseline and 4 weeks. | 3.Quality of Life Scale (QOLS) at baseline and 4 weeks. | 4.Nystagmus time at baseline and 4 weeks.
4.Nystagmus time
时间窗: 1.Berg Balance Scale (BBS) at baseline and 4 weeks. | 2.Dizziness Handicap Inventory (DHI) at baseline and 4 weeks. | 3.Quality of Life Scale (QOLS) at baseline and 4 weeks. | 4.Nystagmus time at baseline and 4 weeks.
次要结局
- 1.Vertigo Symptom Scale Short Form(At baseline and after 4 weeks)